We have updated our Aphria research pitch, including the impact of COVID-19 on our forecast. We have also updated our recommendation, price target, and cannabis price/demand curves. We have also made our Aphria financial model available.
COVID-19
2 posts
We view the current market meltdown as being directly correlated with the increase in the average infection rate per infected person in the U.S. The actions taken by the U.S. government to date (“15 Days to Slow the Spread” and trillion-dollar stimulus) will not be enough to slow the infection rate enough quickly enough in our opinion for a stabilization of prices to occur. When material enough action is taken to slow the spread, we believe institutional investors will have a clearer idea as to when a return to normalcy will occur. At that time, we believe buying certain non-profitable […]